Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.0%

17 terminated/withdrawn out of 846 trials

Success Rate

95.4%

+8.9% vs industry average

Late-Stage Pipeline

5%

39 trials in Phase 3/4

Results Transparency

0%

1 of 356 completed trials have results

Key Signals

91 recruiting1 with results14 terminated

Enrollment Performance

Analytics

N/A
236(79.5%)
Phase 3
24(8.1%)
Phase 4
15(5.1%)
Phase 2
14(4.7%)
Phase 1
8(2.7%)
297Total
N/A(236)
Phase 3(24)
Phase 4(15)
Phase 2(14)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (846)

Showing 20 of 846 trials
NCT07739394Not Yet Recruiting

Diazoxide in the Treatment of Type 1 Glycogenosis

Role: lead

NCT07736859Enrolling By Invitation

Satisfaction of Hysterosalpingo-Foam Sonography

Role: lead

NCT07676448Not Yet Recruiting

Performance of Amino Acid Positons Emission Tomography in Brain Metastases

Role: lead

NCT07698743Recruiting

Eating Disorders in Patients With Phenylketonuria

Role: lead

NCT07691580Not ApplicableRecruiting

Evaluation of Biomechanical Forced During the Practice of Endoscopic Retrograde Cholangiopancreatography

Role: collaborator

NCT02845518Not ApplicableCompleted

Study of Cardiac MRI in the Follow up Assessment of Patients With PAH (EVITA)

Role: lead

NCT07666464Phase 3Recruiting

Comparison of Early Pleural Irrigation Strategy With Saline to the Standard of Care for the Management of Complicated Pleural Infections.

Role: collaborator

NCT07679802Not ApplicableNot Yet Recruiting

Time-controlled Adaptive Ventilation (TCAV) Compared With Conventional Ventilation in Patients With Moderate-to-severe Acute Respiratory Distress Syndrome (ARDS) Secondary to Community-acquired Pneumonia

Role: lead

NCT05080296Completed

Evaluation of the Use of Machine Learning Techniques to Classify Neurodegenerative PARKinsonian Syndromes (Artificial Intelligence)

Role: lead

NCT06463093Completed

Differential Diagnosis of Cognitive Disorders of Psychiatric or Neurodegenerative Origin

Role: lead

NCT05934994Not ApplicableRecruiting

Contribution of MUltiparametric Analysis in Bone Scintigraphy for the Characterisation of Solitary Bone Lesions

Role: lead

NCT03364296Not ApplicableCompleted

Biological Dating of Cerebral Ischemia With GST-π/PRDX1 to Detect Patients With Stroke of Unknown Onset Within the Therapeutic Window of Thrombolysis

Role: lead

NCT02446327Not ApplicableCompleted

The Metabolic Road to Diastolic Heart Failure: Diastolic Heart Failure Study

Role: lead

NCT04157166Not ApplicableCompleted

Evaluation of an Accelerated Body-whole Bone CT Procedure With the CZT(Cadmium-Zinc-Telluride) "VERITON-CT ™" Camera

Role: lead

NCT03347760Not ApplicableCompleted

Pilot Study Evaluating Somatostatin Receptor's PET Imaging to Detect Inflammatory Phases of Myocarditis

Role: lead

NCT06828705Completed

Establish the First International Database on Semi-quantitative Values Obtained in Scintigraphy With Datscan® in Cadmium-Zinc-Telluride Camera

Role: lead

NCT06126588Phase 2Recruiting

Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial

Role: lead

NCT04764721Not ApplicableCompleted

Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID-19

Role: lead

NCT06614205Completed

Tumor Absorbed Dose-Response Relationship in Patients Treated With 177Lu-DOTATATE for Meningioma

Role: lead

NCT06858995Completed

Experience of 177Lu-PSMA-617-administration on Port Reservoir (TIVAP)

Role: lead